Health

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content

LONDON, Jan. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement ofCortellis CMC Intelligence™, the world's only organized, timely and accurate source of Chemistry, ...

2021-01-20 16:15 6562

Innodem Neurosciences Receives 6 Million US Dollars of Financing From Morningside Group

MONTREAL, Jan. 20, 2021 /PRNewswire/ -- Innodem Neurosciences, a Montreal-based company, has closed a Series A financing round led byMorningside Ventures to support the development and commercialization of its proprietary, patented, digital biomarking technology of neurodegenerative diseases such...

2021-01-20 12:00 2797

Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China

SINGAPORE, Jan. 20, 2021 /PRNewswire/ -- Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has entered into a strategic cooperation with Penumbra, Inc., an NYSE listed, global healthcare company ...

2021-01-20 10:39 3656

Sirtex Medical announces collaboration update with OncoSec Medical

Collaboration provides Sirtex the right to co-promote OncoSec lead product candidate TAVO™ for the treatment of advanced melanoma WOBURN, Massachusetts, Jan. 19, 2021 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted cancer therapies, announced an ad...

2021-01-19 22:00 6255

Puhui Investments Announces Successful Initial Public Offering of Two Healthcare Industry Investments

BEIJING, Jan. 19, 2021 /PRNewswire/ -- Puhui Wealth Investment Management Co., Ltd. (Nasdaq: PHCF)("Puhui" or the "Company"), a third-party wealth management service provider with a focus on wealth management services for high net worth ("HNW") individuals and corporate clients as well as asset m...

2021-01-19 22:00 2824

Ortho Clinical Diagnostics Announces Launch of Initial Public Offering

RARITAN, N.J., Jan. 19, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the launch of its in...

2021-01-19 21:57 1572

CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care

CytoSorb now commercially available in Korea – one of the leading economies in Asia - to treat cytokine storm and other illnesses in critically-ill and cardiac surgery patients MONMOUTH JUNCTION, N.J., Jan. 19, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunot...

2021-01-19 20:08 6635

Virtual Visits and Connected Health Solutions Provide Better Care Delivery and Optimize ROI

Integrated solutions to offer greater value to stakeholders along the healthcare value chain, finds Frost & Sullivan SANTA CLARA, Calif., Jan. 19, 2021 /PRNewswire/ -- Telehealth's accelerated adoption during the COVID-19 pandemic has demonstrated the value that providers and payors can receive ...

2021-01-19 20:03 1515

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)

SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failur...

2021-01-19 19:01 2931

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization

BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen qu...

2021-01-19 16:00 1414

Medtec China 2021 Rolls Out New Exhibiting Zone of Advanced Medical Equipment Design & Manufacturing Services

SHANGHAI, Jan. 19, 2021 /PRNewswire/ -- China's medical device market is expected to surpass900 billion yuan in size by 2022. Advanced medical products, however, are currently primarily imported. Last year,China called for actions to shore up its weak spot in advanced medical devices, accelerate ...

2021-01-19 09:30 3718

Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia

SAN FRANCISCO and SUZHOU, China, Jan. 19, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-01-19 08:00 8373

Oncologist Herbert Loong Joins George Clinical Scientific Leadership

OVERLAND PARK, Kansas, Jan. 18, 2021 /PRNewswire/ -- Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based inHong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research ...

2021-01-18 23:00 3595

Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs

* Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year * LAPSTriple Agonist, an innovative triple-acting new drug for NASH treatment, indication expansion * Efpeglenatide met the primary endpoint for global Phase 3 * Striving for developing rare diseases such as...

2021-01-18 22:00 3124

Regent Pacific Group Limited Announces the Successful Launch of Fortacin(TM) in Hong Kong, Upcoming Launches in Taiwan and Macau and Related Business Updates

HONG KONG, Jan. 18, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's ...

2021-01-18 21:21 11139

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy

BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has granted PRior...

2021-01-18 19:00 2187

New report from FDI World Dental Federation tackles oral health inequalities and outlines strategies to improve oral healthcare over the next ten years

·  Oral conditions such as tooth decay, gum disease, tooth loss and oral cancer are the most widespread noncommunicable diseases worldwide – impacting 3.5 billion people – and have severe and significant health, societal, and economic impacts. ·  Oral health professionals must be actively includ...

2021-01-18 19:00 3229

Everest Medicines Announces Amended Agreement with Spero Therapeutics

SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts ofAsia, today announced that under an amen...

2021-01-18 18:05 6929

DoctorOnCall Aid Relief For Flood Victims in Pahang with Free Telehealth and Medical Assistance Programme

KUALA LUMPUR, Malaysia, Jan. 18, 2021 /PRNewswire/ -- The State of Pahang has been badly affected by the recent torrential rain and is one of the hardest hit in Semenanjung Malaysia. DoctorOnCall,Malaysia's first and largest digital health platform, reached out to help lighten the burden of those...

2021-01-18 14:10 2850

MFine Raises $16m From New & Existing Investors Led by Heritas Capital as Adoption of Digital Health Soars in India Amidst COVID-19 Pandemic

SINGAPORE and BENGALURU, India, Jan. 18, 2021 /PRNewswire/ -- India's leading Digital Health startupMFine has raised $16m in a new funding round led byHeritas Capital with participation from Singapore-based family office of Y'S Investment Pte Ltd. Existing MFine investors ...

2021-01-18 13:00 2369
1 ... 545546547548549550551 ... 563